Novel Dopamine D3 Receptor Selective Antagonists/partial Agonists With High Affinity And Metabolic Stability For Treatment Of Neuropsychiatric Disorders
Technology
E-053-2016
Patent ID
E-053-2016-1-US-04
Country
US
Application Type
National Stage
Patent Status
Issued
Patent Number
11299476
Publication Number
US-2020-0291000
Application Number
16/084,093
IC
NIDA
Date Filed
Date Issued